Prominent publications by Brian J Golbourn

KOL Index score: 9337

Magnetic Resonance Image-guided Focused Ultrasound (MRgFUS) has been used to achieve transient blood brain barrier (BBB) opening without tissue injury. Delivery of a targeted ultrasonic wave causes an interaction between administered microbubbles and the capillary bed resulting in enhanced vessel permeability. The use of MRgFUS in the brainstem has not previously been shown but could provide value in the treatment of tumours such as Diffuse Intrinsic Pontine Glioma (DIPG) where the ...

Known for Brain Barrier |  Focused Ultrasound |  Bbb Opening |  Drug Delivery |  Administered Microbubbles
KOL Index score: 8495

Malignant astrocytomas are highly invasive brain tumors. The Rho family of cytoskeletal GTPases are key regulators of astrocytoma migration and invasion; expression of the guanine nucleotide exchange factor ECT2 is elevated in primary astrocytomas and predicts both survival and malignancy. Mice bearing orthotopically implanted astrocytoma cells with diminished ECT2 levels following ECT2 knockdown exhibit longer survival. Although ECT2 is normally expressed in the nucleus, we show that ...

Known for Astrocytoma Cells |  Ect2 Expression |  Amoeboid Phenotype |  Binding Protein |  Cdc42 Gtp
KOL Index score: 7972

Malignant gliomas are highly proliferative and invasive neoplasms where total surgical resection is often impossible and effective local radiation therapy difficult. Consequently, there is a need to develop a greater understanding of the molecular events driving invasion and to identify novel treatment targets. Using microarray analysis comparing normal brain samples and mesenchymal glioblastoma multiforme (GBM), we identified over 140 significant genes involved in cell migration and ...

Known for Gbm Invasion |  Lim Kinase |  Cell Migration |  Actin Filaments |  Malignant Gliomas
KOL Index score: 7727

Proliferating cancer cells are characterized by high rates of glycolysis, lactate production, and altered mitochondrial metabolism. This metabolic reprogramming provides important metabolites for proliferation of tumor cells, including glioblastoma. These biological processes, however, generate oxidative stress that must be balanced through detoxification of reactive oxygen species (ROS). Using an unbiased retroviral loss-of-function screen in nontransformed human astrocytes, we ...

Known for Oxidative Stress |  Tumor Cells |  Glioblastoma Growth |  Pink1 Loss |  Metabolic Reprogramming
KOL Index score: 7247

Inhibition of Aurora kinase B has been evaluated as a therapy to block solid tumor growth in breast cancer, hepatocellular carcinoma, lung adenocarcinoma, and colorectal cancer models. Aurora kinase inhibitors are in early clinical trials for the treatment of leukemia. We hypothesized that Aurora B inhibition would reduce malignant glioma cell viability and result in impaired tumor growth in vivo. Aurora B expression is greater in cultured malignant glioma U251 cells compared to ...

Known for Aurora Kinase |  Glioma Cell |  Tumor Growth |  Azd1152 Hqpa |  Serine Threonine
KOL Index score: 7243

Medulloblastoma comprises four molecular subgroups of which Group 3 medulloblastoma is characterized by MYC amplification and MYC overexpression. Lymphoma cells expressing high levels of MYC are susceptible to apoptosis following treatment with inhibitors of mitosis. One of the key regulatory kinases involved in multiple stages of mitosis is Aurora kinase B. We hypothesized that medulloblastoma cells that overexpress MYC would be uniquely sensitized to the apoptotic effects of Aurora B ...

Known for Aurora Kinase |  Neoplastic Humans |  Myc Overexpressing |  Cell Tumor |  Molecular Subgroups
KOL Index score: 7051

Pediatric high-grade astrocytomas (pHGA) and diffuse intrinsic pontine gliomas (DIPG) are devastating malignancies for which no effective therapies exist. We investigated the therapeutic potential of PARP1 inhibition in preclinical models of pHGA and DIPG. PARP1 levels were characterized in pHGA and DIPG patient samples and tumor-derived cell lines. The effects of PARP inhibitors veliparib, olaparib, and niraparib as monotherapy or as radiosensitizers on cell viability, DNA damage, and ...

Known for Ribose Polymerase |  Intrinsic Pontine |  Parp1 Activity |  Pediatric Diffuse |  Cell Lines
KOL Index score: 6964

Medulloblastoma is the most common malignant pediatric brain tumor, with metastases present at diagnosis conferring a poor prognosis. Mechanisms of dissemination are poorly understood and metastatic lesions are genetically divergent from the matched primary tumor. Effective and less toxic therapies that target both compartments have yet to be identified. Here, we report that the analysis of several large nonoverlapping cohorts of patients with medulloblastoma reveals MET kinase as a ...

Known for Sonic Hedgehog |  Signal Transduction |  Shh Medulloblastoma |  Tumor Cell |  Mice Mice
KOL Index score: 6772

First-line cancer therapies such as alkylating agents and radiation have limited survival benefits for Glioblastoma (GBM) patients. Current research strongly supports the notion that inhibition of aberrant tumor metabolism holds promise as a therapeutic strategy when used in combination with radiation and chemotherapy. Hexokinase 2 (HK2) has been shown to be a key driver of altered metabolism in GBM, and presents an attractive therapeutic target. To date, no study has fully assessed the ...

Known for Hexokinase 2 |  Tumor Metabolism |  Glioblastoma Gbm |  Cell Lines |  Dna Damage
KOL Index score: 6724

Alkylating agents are a first-line therapy for the treatment of several aggressive cancers, including pediatric glioblastoma, a lethal tumor in children. Unfortunately, many tumors are resistant to this therapy. We sought to identify ways of sensitizing tumor cells to alkylating agents while leaving normal cells unharmed, increasing therapeutic response while minimizing toxicity. Using an siRNA screen targeting over 240 DNA damage response genes, we identified novel sensitizers to ...

Known for Alkylating Agents |  Animal Drug Resistance |  Ataxia Telangiectasia |  Dna Glycosylase |  Tumor Cells
KOL Index score: 6246

Glioblastoma (GBM) is the most common primary brain tumor in adults. Despite current advances in therapy consisting of surgery followed by chemotherapy and radiation, the overall survival rate still remains poor. Therapeutic failures are partly attributable to the highly infiltrative nature of tumor adjacent to normal brain parenchyma. Recently, evidence is mounting to suggest that actin cytoskeleton dynamics are critical components of the cell invasion process. Drebrin is an ...

Known for Role Drebrin |  Cell Motility |  Brain Tumor |  Actinbinding Protein |  Actin Filament Organization
KOL Index score: 6066

The cofilin pathway plays a central role in the regulation of actin polymerization and the formation of cell membrane protrusions that are essential for cell migration. Overexpression of cofilin has been linked to the aggressiveness of a variety of different cancers. In these cancers, the phosphorylation of cofilin at Ser3 is a key regulatory mechanism modulating cofilin activity. The activation status of cofilin has been directly linked to tumor invasion. Accordingly, in this study, we ...

Known for Cofilin Activity |  Cell Migration |  Activation Status |  Local Invasiveness |  Actin Polymerization
KOL Index score: 5609

Cdc42 is a Rho-GTPase which plays a major role in regulating cell polarity and migration by specifying the localization of filopodia. However, the role of Cdc42 in GBM invasion has not been thoroughly investigated. We generated stable doxycycline-inducible clones expressing wild type (WT)-, constitutively active (CA)-, and dominant negative (DN)-Cdc42 in three different human glioma cell lines. Expression of CA-Cdc42 significantly increased the migration and invasive properties of ...

Known for Role Cdc42 |  Cell Adhesion |  Glioblastoma Multiforme |  Malignant Gliomas |  Migration Invasion
KOL Index score: 5214

Pediatric ependymomas are highly recurrent tumors resistant to conventional chemotherapy. Telomerase, a ribonucleoprotein critical in permitting limitless replication, has been found to be critically important for the maintenance of tumor-initiating cells (TICs). These TICs are chemoresistant, repopulate the tumor from which they are identified, and are drivers of recurrence in numerous cancers. In this study, telomerase enzymatic activity was directly measured and inhibited to assess ...

Known for Pediatric Ependymoma |  Telomerase Activity |  Alternative Lengthening |  Maintenance Mechanisms |  Cell Tumor
KOL Index score: 4371

We recently reported that atypical teratoid rhabdoid tumors (ATRTs) comprise at least two transcriptional subtypes with different clinical outcomes; however, the mechanisms underlying therapeutic heterogeneity remained unclear. In this study, we analyzed 191 primary ATRTs and 10 ATRT cell lines to define the genomic and epigenomic landscape of ATRTs and identify subgroup-specific therapeutic targets. We found ATRTs segregated into three epigenetic subgroups with distinct genomic ...

Known for Rhabdoid Tumor |  Differential Methylation |  Epigenomic Analyses |  Specific Therapeutic |  Smarcb1 Protein


Brian J Golbourn: Influence Statistics

Sample of concepts for which Brian J Golbourn is among the top experts in the world.
Concept World rank
cells rasal2 #5
cdc42 expressing #6
enhanced local migration #6
cdc42 glioblastoma #6
inhibitors bms5 #6
survival cdc42 #6
lim kinasecofilin pathway #6
bms5 cucurbitacin #6
fak neoplastic genes #6
role activated cdc42 #6
cdc42 gbm #6
cdc42 gbm invasion #6
temporary bbb opening #7
dipg intact #7
dipg17 brainstem #7
mrgfus dipg #7
mrgfus murine #7
drug dipg17 #7
study dipg17 #7
normal murine brainstem #7
doxorubicin mrgfus #7
doxorubicin mrgfustreated animals #7
mrgfus temporary #7
dipg doxorubicin #7
mrgfus drug delivery #7
dipg17 xenografts #7
tumours mrgfus #7
cofilin cfl pathway #8
gbm invasiveness phosphorylation #8
data limk #8
brainstem mrgfus #8
limk bms5 #8
cofilin regulating kinases #8
gbm invasion genes #8
expressed parp1 #9
niraparib effective #9
dipg benzimidazoles blotting #9
parp1 dipg #9
phga cells #9
gbm limk1 #9
model phga #9
niraparib cell viability #9
relative cell niraparib #9
cell niraparib #9
phga dipg #9
niraparib parp1 activity #9
orthotopic phga #9
phga diffuse #9
activated cdc42 binds #9
niraparib dna damage #9

Key People For Aurora Kinase

Top KOLs in the world
Subrata Sen
aurora kinase pancreatic cancer chromosomal instability
William C Earnshaw
mitotic chromosomes centromere protein caspase activation
Mar Carmena
polo kinase cell division centromere protein
Hiroshi Katayama
aurora kinase hemorrhagic shock cancer cells
Erich A Nigg
cell cycle protein kinase centrosome aberrations
Stephen S Taylor
spindle checkpoint gene expression aurora kinases

Brian J Golbourn:Expert Impact

Concepts for whichBrian J Golbournhas direct influence:Aurora kinase,  3 medulloblastoma,  Effective therapy,  Tumor cell,  Inbred nod mice,  Pediatric ependymoma,  Supratentorial ependymoma,  Cofilin pathway.

Brian J Golbourn:KOL impact

Concepts related to the work of other authors for whichfor which Brian J Golbourn has influence:Focused ultrasound,  Brain tumors,  Rhabdoid tumor,  Dna repair,  Aurora kinase,  Parp inhibitors,  Glioblastoma cells.



Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

John G. Rangos Sr. Research Center, Children’s Hospital of Pittsburgh, and Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA | Department of Neurological Surgery, University of Pittsburgh School of M

FREE Custom List